A stylized globe graphic, with the EU area emphasized
ISIDORe project home / Events / ISIDORe USER’s CONFERENCE

ISIDORe USER's CONFERENCE

Discover groundbreaking scientific research in infectious diseases at the ISIDORe project’s online scientific conference. Explore projects supported by ISIDORe over the past two years, including studies on COVID-19 variants, Mpox, and other priority pathogens. Register now for free to join the conference and connect with leading experts in the field.

Date: 28th May, 2024 – 09:00 – 18:00 CEST

Location: Online

As the ISIDORe project enters its second year, we invite you to join us in discovering new scientific projects that have come to fruition thanks to our support!

Over the past two years, the ISIDORe project has facilitated rapid research response and epidemic preparedness through the launch of calls for proposals targeting SARS-CoV-2 variants, the Mpox virus, and a wide variety of pathogens listed as priorities for epidemic preparedness.

To celebrate these achievements and to showcase the successes of the project, we are organizing an online scientific conference for project participants to present their research findings. This conference will provide an excellent platform for scientific exchange and networking, allowing us to highlight the diverse range of projects supported by ISIDORe and their impact on the field of infectious disease. The event is proudly supported by our partner, the UK-ICN.

The conference will be structured around the thematic areas of our calls for proposals, including COVID-19 and SARS-CoV-2; RG4 Pathogens; Vector-Borne Pathogens; Mpox; and other pathogens with pandemic potential. We are delighted to announce that several keynote speakers will provide insights into the current state of research within their respective fields of expertise.

Please note that the event will be exclusively accessible online, and registration is free but mandatory. Registered participants will receive an email containing the Zoom link 24 hours prior to the conference.